Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Pharmacokinetics and Safety of Solithromycin in Adolescents and Children

ClinicalTrials.gov ID: NCT02268279

Public ClinicalTrials.gov record NCT02268279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents and Children With Suspected or Confirmed Bacterial Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Pediatric study to evaluate the safety and pharmacokinetics of solithromycin (oral and intravenous) in children ages 0 to 17

Study identification

NCT ID
NCT02268279
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Melinta Therapeutics, Inc.
Industry
Enrollment
84 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2014
Primary completion
Sep 30, 2016
Completion
Sep 30, 2016
Last update posted
Jun 8, 2017

2015 – 2016

United States locations

U.S. sites
31
U.S. states
23
U.S. cities
31
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72202
Not listed Orange California 92868
Not listed Palo Alto California 94305
Not listed San Diego California 92123
Not listed Jacksonville Florida 32209
Not listed Tampa Florida 33606
Not listed Chicago Illinois 60611
Not listed Iowa City Iowa 52242
Not listed Wichita Kansas 67214
Not listed Louisville Kentucky 40202
Not listed Shreveport Louisiana 71103
Not listed Baltimore Maryland 21201
Not listed St Louis Missouri 63110
Not listed Omaha Nebraska 68198
Not listed Hackensack New Jersey 07601
Not listed Albuquerque New Mexico 87131
Not listed Albany New York 12208
Not listed Brooklyn New York 11203
Not listed Chapel Hill North Carolina 27599
Not listed Cleveland Ohio 44103
Not listed Toledo Ohio 43606
Not listed Portland Oregon 97239
Not listed Memphis Tennessee 38105-3678
Not listed Nashville Tennessee 37232
Not listed Austin Texas 78723
Not listed Houston Texas 77030
Not listed Splendora Texas 77372
Not listed Richmond Virginia 23298
Not listed Seattle Washington 98105
Not listed Morgantown West Virginia 26506
Not listed Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02268279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2017 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02268279 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →